Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Ранг среди акций #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Цена акции
$0.00185055
Рыночная капитализация
$48.29K
Изменение (1 день)
-3.55%
Изменение (1 год)
30.31%
Страна
GB
Торговля Nuformix plc (NFX)

Категория

Коэффициент P/S для Nuformix plc (NFX)
Коэффициент P/S на September 2026 TTM: 0.00
Согласно последним финансовым отчетам и цене акций Nuformix plc, текущий коэффициент P/S (TTM) составляет 0.00. В конце 2024 он составлял 0.00.
История P/S для Nuformix plc с 2014 по 2026
Коэффициент P/S в конце каждого года
Год P/S Изменить
2026 (TTM) 0.00 0.00%
2025 0.00 0.00%
2024 0.00 0.00%
2023 0.00 -100.00%
2022 116.70 74.68%
2021 66.81 87.30%
2020 35.67 81.62%
2019 19.64 -95.96%
2018 485.61 0.00%
2017 0.00 -100.00%
2016 2.23 0.00%
2014 0.00 0.00%
Коэффициент P/S для аналогичных компаний или конкурентов
Компания P/S Разница P/S Страна
10.44 -
US
26.12 -
US
3.76 -
AU
12.01 -
NL
- -
CH